Artelo Biosciences Inc.

NASDAQ: ARTLW · Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM

Artelo Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Net Income
-1.6M -2.17M -3.34M -2.33M -2.45M -1.97M -2.55M -1.89M -2.25M -1.87M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a 61.00 62.00
Stock-Based Compensation
225K 354K 608K 607K 619K 624K 571K 519.83K 618.36K 341.45K
Other Working Capital
169K -68K -4K 139K 264K -594K -80K n/a -150.55K 25.7K
Other Non-Cash Items
-187K -124K -137K -70K -23K 19K -1K 6.82K 1.33K -1.33K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-62K -248K 575K 97K -113K -731K 52K -181.31K -150.55K 25.7K
Operating Cash Flow
-1.62M -2.19M -2.29M -1.7M -1.97M -2.05M -1.93M -1.54M -1.78M -1.5M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-2.35M -5.8M -2.18M -7.86M -740K -2.45M -10.76M n/a n/a n/a
Sales Maturities Of Investments
2.75M 8M 3.98M 4.78M 4.72M 2.7M 1.88M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a -3.44M 510.69K n/a
Investing Cash Flow
399K 2.2M 1.8M -3.08M 3.98M 257K -8.88M -3.44M 510.69K -510.69K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a 1.11M 593.36K 5.32M
Financial Cash Flow
-1.25M n/a 134K n/a -134K n/a 18.26M 1.6M 617.48K 5.32M
Net Cash Flow
-1.2M 28K -248K -4.99M 1.77M -1.81M 7.42M -3.42M -654.14K 3.32M
Free Cash Flow
-1.62M -2.19M -2.29M -1.7M -1.97M -2.05M -1.93M -1.54M -1.78M -1.5M